- Home
- OLMA vs HCI Comparison
OLMA vs HCI Comparison
Compare OLMA & HCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OLMA | HCI |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | OLMA | HCI |
|---|---|---|
| Price | $22.59 | $157.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | $42.00 | ★ $230.00 |
| AVG Volume (30 Days) | ★ 1.3M | 153.5K |
| Earning Date | 03-17-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 1.01% |
| EPS Growth | N/A | ★ 32.29 |
| EPS | N/A | ★ 15.80 |
| Revenue | N/A | ★ $816,578,000.00 |
| Revenue This Year | N/A | $18.28 |
| Revenue Next Year | N/A | $11.03 |
| P/E Ratio | ★ N/A | $10.00 |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $2.86 | $115.65 |
| 52 Week High | $36.26 | $210.50 |
Technical Indicators
Market Signals| Indicator | OLMA | HCI |
|---|---|---|
| Relative Strength Index (RSI) | 36.81 | 39.70 |
| Support Level | $22.40 | $159.36 |
| Resistance Level | $24.32 | $167.71 |
| Average True Range (ATR) | 1.85 | 4.89 |
| MACD | -0.34 | 0.99 |
| Stochastic Oscillator | 3.66 | 40.04 |
Price Performance
Historical ComparisonAbout OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About HCI HCI Group Inc.
HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are insurance operations, TypTap Group, reciprocal exchange operations, real estate operations, and corporate and other. It derives key revenue from the HCPCI Insurance operation segment.